Corticosteroid Sparing Effect of Certolizumab in Crohn's Disease

NCT00349752 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
174
Enrollment
INDUSTRY
Sponsor class

Stopped Recruitment was stopped early due to slow enrolment of this population. With no safety concerns, the study continued normally for subjects already recruited

Conditions

Interventions

Sponsor

UCB Pharma